Trademark search for:

AUREXSERO

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2010-12-31 — Application filed
2011-02-10 — Sn assigned for sect 66a appl from ib
2011-02-11 — Application filed
2011-02-15 — Application filed
2011-02-25 — Approved for pub - principal register
2011-02-25 — Assigned to examiner
2011-03-16 — Notice of publication
2011-04-05 — Published for opposition
2011-06-21 — Registered-principal register
2011-07-21 — Grant of protection created, to be sent to ib
2011-09-14 — Final disposition recorded
2011-09-14 — Final disposition recorded
2011-12-18 — Notification processed by ib
2013-04-28 — New representative at ib received
2015-07-03 — Change of owner received from ib
2018-01-26 — Cancelled section 71
2018-09-26 — Total invalidation of reg ext protection created
2018-09-27 — Invalidation processed
2018-09-28 — Total invalidation of reg ext protection sent to ib
2018-12-15 — Total invalidation processed by the ib
2020-12-31 — Final status recorded
2021-11-27 — Death of international registration
2021-11-27 — Notification of effect of cancellation of intl reg mailed

Owner Information

Glaxosmithkline Biologicals S.A.
BE

NOVARTIS AG
CH

Correspondent

Schneider Feldmann AG Patent- und Markenanwälte
Beethovenstrasse 49,
Postfach 2792
CH-8022 Zürich,

Filing Details

Filing Date:
2010-12-31

Status Date:
2020-12-31

Category:
Pharmaceuticals

Filing Year:
2010

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.